Cytokine storm after cessation of tocilizumab in a patient with refractory Takayasu arteritis

Affiliations

• ¹ Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
• ² Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan; Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science Technology Agency, 4-1-8, Honcho, Kawaguchi, Saitama 332-0012, Japan. Electronic address: ynakaoka@cardiology.med.osaka-u.ac.jp.
• ³ Department of Metabolic Medicine, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan.
• ⁴ Laboratory of Immune Regulation, Immunology Frontier Research Center, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
• ⁵ Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan.